The 11 references in paper A. Zaytsev A., D. Antipushina N., I. Sivokozov V., А. Зайцев А., Д. Антипушина Н., И. Сивокозов В. (2014) “Практические возможности ПЭТ / КТ в оценке активности и распространенности саркоидоза // Real-life PET / CT abilities to assess activity and extension of sarcoidosis” / spz:neicon:pulmonology:y:2013:i:6:p:119-122

1
Чучалин А.Г., Визель А.А., Амиров Н.Б. (ред.). Саркоидоз. Учеб.-метод. пособие. Казань: Медицина, 2010.
(check this in PDF content)
2
Wells A., Hirani N., et al. Interstitial lung disease guideline: the British and the Irish Thoracic Society Thoracic Society of Australia and New Zealand Thoracic Society in collaboration with the Thoracic Society of Australia and Disease Guideline Group, a subgroup of the British Thoracic Society Standards. Thorax 2008; 63; 1–58.
(check this in PDF content)
3
Soussan M., Augier A., Brillet P. et al. Functional Imaging in Extrapulmonary Sarcoidosis: FDG-PET/CT and MR Features. Clin. Nucl. Med. 2013. Aviable at: http://journals. lww.com/nuclearmed/Abstract/publishahead/Functional_ Imaging_in_Extrapulmonary_Sarcoidosis_.99737.aspx
(check this in PDF content)
4
Skali H., Schulman A., Dorbala S. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr. Cardiol. Rep. 2013; 15 (4): 352.
(check this in PDF content)
5
Ng D., Jacobs M., Mantil J. Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis. Clin. Nucl. Med. 2006; 31 (7): 373–375.
(check this in PDF content)
6
Aide N., Benayoun M., Kerrou K. et al.Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolicresponse to corticosteroid therapy. Br. J. Radiol. 2007; 80 (951): e67–e71.
(check this in PDF content)
7
Inoue K., Goto R., Shimomura H., Fukuda H.FDGPET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment. Springerplus 2013; 2 (1): 113.
(check this in PDF content)
8
Videnovic7Ivanov J., Vucinic7Mihailovic V., Artiko V. et al. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis. Clin. Nucl. Med. 2013; 38 (7): 516–521.
(check this in PDF content)
9
Imperiale A., Riehm S., Braun J. Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement. Quart. J. Nucl. Med. Mol. Imag. 2013; 57 (2): 177–186.
(check this in PDF content)
10
Coker R.Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs 2007; 67 (8): 1139–1147.
(check this in PDF content)
11
Ambrosini V., Zompatori M., Fasano L. et al. 18F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: Results of a Preliminary Prospective Study. Clin. Nucl. Med. 2013; 38 (4): e171–e177. Информация об авторах
(check this in PDF content)